Management of Healthcare Workers with Fever and Thrombocytopenia
Diagnostic Approach
- The Centers for Disease Control and Prevention recommends obtaining a manual differential white blood cell count to assess for left shift, measuring D-dimer levels, and considering empiric doxycycline therapy in healthcare workers with low-grade fever, mild thrombocytopenia, and borderline elevated CRP, while investigating for tickborne rickettsial diseases and other vector-borne infections 1, 2
- A complete blood count with manual differential should be obtained to assess for left shift (≥6% bands or total band count ≥1500 cells/mm³), which indicates bacterial infection even without leukocytosis 3, 4
- D-dimer levels should be measured, with values 3-4 times normal (>1.5-2.0 μg/mL) indicating significant thrombin generation and warranting close monitoring or admission 5, 6, 7
Clinical Assessment
- The American College of Physicians suggests that a detailed exposure history, including outdoor activities, tick exposures, recent travel, and animal contacts, should be obtained from the patient 1, 9
- A thorough skin examination for rash, tick attachment sites, and petechiae should be performed 1, 9
- The patient should be assessed for warning signs of severe disease, such as orthostatic hypotension, tachypnea, altered mental status, and signs of plasma leakage 10, 2
Empiric Treatment
- The Centers for Disease Control and Prevention recommends starting doxycycline 100 mg orally twice daily immediately if there is a history of tick exposure, presentation occurs during April-September in endemic areas, or thrombocytopenia with normal or low-normal WBC count is present 1, 9
- Doxycycline should not be withheld pending serologic confirmation, as the combination of fever, thrombocytopenia, and borderline elevated CRP without leukocytosis is highly suggestive of tickborne rickettsial disease 1, 9
Monitoring and Follow-up
- Platelet counts should be monitored every 24 hours (or every 4-12 hours if declining) until stable or improving 2, 8
- PT, D-dimer, and fibrinogen levels should be monitored if coagulopathy develops or worsens 5, 7
- Clinical response to therapy should be assessed within 24-48 hours of doxycycline initiation 1
- Repeat serology should be performed at 2-4 weeks to confirm diagnosis of tickborne diseases 1